Towards Healthcare
DNA Synthesis Market to Grow at 17.42% CAGR till 2034

DNA Synthesis Market Trends Indicate Strong Demand in Future Applications

Projections indicate that, the global DNA synthesis market will increase from USD 4.62 billion in 2024 to USD 23.1 billion by 2034, experiencing a CAGR of 17.42% over the next 10 years. The DNA synthesis market is rising due to the rise in gene therapies for the treatment of cancer, rare diseases, and other chronic conditions. North America leads the market due to the presence of major market players.

Content

  • Last Updated: 16 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The DNA synthesis market is worth USD 5.43 billion in 2025, and by 2034, it is forecasted to hit USD 23.1 billion, registering a CAGR of 17.42% over the decade.

North America is currently leading the DNA synthesis market share 41% due to rising cancer cases and other chronic conditions.

The DNA synthesis market includes five segments such as by product type, by technology, by application, by end-user, and by region.

Some key players include Thermo Fisher Scientific, Twist Biosciences, GenScript Biotech, Agilent Technologies, etc.

Genetics is used in medicine to diagnose hereditary illnesses, forecast disease risk, customise care, and provide new treatments like pharmacogenetics and gene therapy.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions